Bio-Techne TECH Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $51.05M+34.3% | $38.01M-0.5% | $38.19M— | —— | $22.59M-35.3% | ||
| $24.17M-2.2% | $24.71M+1.5% | $24.34M-10.2% | $27.11M-1.7% | $27.57M+1.8% | ||
| $10.5M-24.8% | $13.96M+19.5% | $11.68M+157% | $4.55M-60.1% | $11.39M-22.6% | ||
| $86.66M+5.2% | $82.41M+199% | $27.59M-71.9% | $98.2M+139% | $41.12M-51.2% | ||
| $9.09M+53.5% | $5.92M+10.4% | $5.36M+9.7% | $4.89M-51.7% | $10.12M+48.4% | ||
| -$5.82M+1.8% | -$5.92M-1,079% | $605K— | $0+100% | -$8.87M-76.3% | ||
| $12.52M+0.4% | $12.47M+0.2% | $12.44M+0.5% | $12.39M-1.5% | $12.58M-1.2% | ||
| —— | —— | $24K-100.0% | $100.06M0.0% | $100.05M— | ||
| $60M+50.0% | $40M-13.0% | $46M-8.0% | $50M+525% | $8M— | ||
| -$42.72M+12.8% | -$48.99M-10.8% | -$44.2M+51.1% | -$90.45M-32.9% | -$68.05M+18.8% | ||
| $36.94M+32.3% | $27.92M+262% | -$17.22M-180% | $21.52M+158% | -$36.88M— | ||
| $77.58M+1.4% | $76.49M+244% | $22.22M-76.2% | $93.31M+201% | $31M-60.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bio-Techne generate?
- Bio-Techne (TECH) generated $294.9M in operating cash flow over the trailing twelve months.
- What is Bio-Techne's free cash flow?
- After $25.3M of capital expenditures, Bio-Techne's free cash flow was $269.6M over the trailing twelve months, up 22.1% year over year.
- Where does Bio-Techne's cash flow data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
